These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 32405023)

  • 41. Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.
    Ferguson J; Rosser JI; Quintero O; Scott J; Subramanian A; Gumma M; Rogers A; Kappagoda S
    Emerg Infect Dis; 2020 Aug; 26(8):1679-1685. PubMed ID: 32407284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compassionate Release as a "Right" in the Age of COVID-19.
    Berryessa CM
    Am J Bioeth; 2020 Jul; 20(7):185-187. PubMed ID: 32716795
    [No Abstract]   [Full Text] [Related]  

  • 43. Thoughts from a senior surgeon with an interest in ethics.
    Surgery; 2020 Sep; 168(3):397. PubMed ID: 32624227
    [No Abstract]   [Full Text] [Related]  

  • 44. Ethics in the age of COVID-19.
    Arora A; Arora A
    Intern Emerg Med; 2020 Aug; 15(5):889-890. PubMed ID: 32440984
    [No Abstract]   [Full Text] [Related]  

  • 45. Can I Get Force Majeure from a Novel Coronavirus?
    Clark JR
    Air Med J; 2020; 39(4):235-236. PubMed ID: 32690295
    [No Abstract]   [Full Text] [Related]  

  • 46. Orchestrating Collaborative Research and Clinical Trials during COVID-19 Pandemic - A New Normal.
    Agrawal R
    Ocul Immunol Inflamm; 2020 Nov; 28(8):1163-1165. PubMed ID: 32976047
    [No Abstract]   [Full Text] [Related]  

  • 47. Preferential use of dexamethasone for fetal lung maturation in severe coronavirus disease 2019.
    Dellapiana G; Naqvi M; Leggett C; Tholemeier L; Burwick RM
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100218. PubMed ID: 32844157
    [No Abstract]   [Full Text] [Related]  

  • 48. Beyond acute care: Why collaborative self-management should be an essential part of rehabilitation pathways for COVID-19 patients.
    Wainwright TW; Low M
    J Rehabil Med; 2020 May; 52(5):jrm00055. PubMed ID: 32350542
    [No Abstract]   [Full Text] [Related]  

  • 49. Let's do this Canada! COVID-19, you can't get rid of us without a fight!
    Stiles E
    Can Vet J; 2020 Sep; 61(9):921-922. PubMed ID: 32879516
    [No Abstract]   [Full Text] [Related]  

  • 50. [Data monitoring committees-state of the art and perspectives for the future].
    Fischer T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Dec; 63(12):1511-1518. PubMed ID: 32897407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity".
    Lê MP; Le Beller C; Le Hingrat Q; Jaquet P; Wicky PH; Bunel V; Massias L; Visseaux B; Messika J; Descamps D; Mal H; Timsit JF; Peytavin G
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32988815
    [No Abstract]   [Full Text] [Related]  

  • 52. Five reasons why data on compassionate use of remdesivir deserved publication (and are worth reading).
    Lapadula G
    Swiss Med Wkly; 2020 May; 150():w20265. PubMed ID: 32364611
    [No Abstract]   [Full Text] [Related]  

  • 53. COVID: Its compassionate use.
    Bennett J
    J Vasc Nurs; 2020 Dec; 38(4):163. PubMed ID: 33279103
    [No Abstract]   [Full Text] [Related]  

  • 54. Payment of COVID-19 challenge trials: underpayment is a bigger worry than overpayment.
    Blumenthal-Barby J; Ubel P
    J Med Ethics; 2021 Aug; 47(8):585-586. PubMed ID: 33046591
    [No Abstract]   [Full Text] [Related]  

  • 55. [Not Available].
    De Germond V
    Rev Med Suisse; 2023 Mar; 19(817):492-493. PubMed ID: 36883711
    [No Abstract]   [Full Text] [Related]  

  • 56. Should scientists infect healthy people with the coronavirus to test vaccines?
    Callaway E
    Nature; 2020 Apr; 580(7801):17. PubMed ID: 32218549
    [No Abstract]   [Full Text] [Related]  

  • 57. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
    Grifoni A; Weiskopf D; Ramirez SI; Mateus J; Dan JM; Moderbacher CR; Rawlings SA; Sutherland A; Premkumar L; Jadi RS; Marrama D; de Silva AM; Frazier A; Carlin AF; Greenbaum JA; Peters B; Krammer F; Smith DM; Crotty S; Sette A
    Cell; 2020 Jun; 181(7):1489-1501.e15. PubMed ID: 32473127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracorporeal Blood Purification in Moderate and Severe COVID-19 Patients: A Prospective Cohort Study.
    Rosalia RA; Ugurov P; Neziri D; Despotovska S; Kostoska E; Veljanovska-Kiridjievska L; Kuzmanov D; Trifunovski A; Popevski D; Villa G; Mitrev Z
    Blood Purif; 2022; 51(3):233-242. PubMed ID: 34126617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments?
    Simon GE; Platt R; Watanabe JH; Bindman AB; John London A; Horberg M; Hernandez A; Califf RM
    Clin Pharmacol Ther; 2022 Jan; 111(1):30-34. PubMed ID: 33895994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Collaborative Platform Trials to Fight COVID-19: Methodological and Regulatory Considerations for a Better Societal Outcome.
    Collignon O; Burman CF; Posch M; Schiel A
    Clin Pharmacol Ther; 2021 Aug; 110(2):311-320. PubMed ID: 33506495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.